BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15093254)

  • 1. Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective.
    Descotes J
    Toxicol Lett; 2004 Apr; 149(1-3):103-8. PubMed ID: 15093254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxicology: role in the safety assessment of drugs.
    Descotes J
    Drug Saf; 2005; 28(2):127-36. PubMed ID: 15691223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotoxicity assessment in the preclinical study of biologically active compounds].
    Uteshev BS; Arzamastsev EV
    Eksp Klin Farmakol; 1996; 59(3):3-8. PubMed ID: 8974580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
    Spanhaak S
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of xenobiotics for direct immunotoxicity in an animal study.
    De Jong WH; Van Loveren H
    Methods; 2007 Jan; 41(1):3-8. PubMed ID: 17161297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of toxic effects on the immune system.
    Gopinath C
    Inflamm Res; 1996 Dec; 45 Suppl 2():S74-8. PubMed ID: 8988406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxic effects of chemicals: A matrix for occupational and environmental epidemiological studies.
    Veraldi A; Costantini AS; Bolejack V; Miligi L; Vineis P; van Loveren H
    Am J Ind Med; 2006 Dec; 49(12):1046-55. PubMed ID: 17036363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods of evaluating immunotoxicity.
    Descotes J
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):249-59. PubMed ID: 16866611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory aspects of immunotoxicology.
    Schulte A; Ruehl-Fehlert C
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):385-9. PubMed ID: 16713214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational immunologic safety evaluation: a perspective.
    Descotes J
    J Immunotoxicol; 2013; 10(1):83-9. PubMed ID: 22967109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?
    Snodin DJ
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):336-55. PubMed ID: 15546688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in understanding adjuvant immunotoxicity mechanisms.
    Batista-Duharte A; Lindblad EB; Oviedo-Orta E
    Toxicol Lett; 2011 Jun; 203(2):97-105. PubMed ID: 21392560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotoxicity of pesticides: perspectives and trends.
    Banerjee BD; Koner BC; Ray A
    Indian J Exp Biol; 1996 Aug; 34(8):723-33. PubMed ID: 8979476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.